S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA M. L. Wang,W. Jurczak,M. Jerkeman,J. Trotman, P. L. Zinani,D. Belada,C. Boccomini,I. W. Flinn,P. Giri,A. Goy, P. A. Hamlin,O. Hermine,J.-Á. Hernández-Rivas, X. Hong,S. J. Kim, D. Lewis, Y. Mishima,M. Özcan,G. F. Perini,C. Pocock, Y. Song,S. E. Spurgeon, J. M. Storring,J. Walewski, J. Zhu, R. Qin,T. Henninger, S. Deshpande,A. Howes,S. Le Gouill,M. DreylingHemaSphere（2022）引用 0|浏览16暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
